Skip to main content
. 2018 Aug 8;9(9):941–946. doi: 10.1021/acsmedchemlett.8b00296

Figure 4.

Figure 4

RAS-GTP and corresponding pERK1/2T202/Y204 levels from HeLa cells that were treated for 30 min with up to 100 μM of compound 22, 30, 32, or 34. EGF treatment (50 ng/mL for 5 min) was used as a positive control for pathway activation. Quantification values for RAS-GTP and pERK1/2T202/Y204 levels are displayed under the respective blots for each compound and are also provided in Table S1. Data are representative of three independent experiments.